The Valley Desk

NCT05683418 · Interventional trial

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

Overall registry status Recruiting

Phase 1

Conditions HR+/HER2-negative Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov